E. Braunwald
Cardiology and Cardiovascular Medicine · 2000–2019
A researcher in the Science corpus: 42 papers; trusts 4 researchers and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Cardiology and Cardiovascular Medicine — 281 citations into it
- Molecular Biology — 49 citations into it
- Cancer Research — 34 citations into it; #1,151 of 1,780 by trust here, #615 by citations
Whom E. Braunwald trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts E. Braunwald overall
Papers from E. Braunwald's perspective
Ordered by how strongly the researchers E. Braunwald trusts endorse each paper. Same corpus, a different order for every researcher.
- Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. (Journal of the American College of Cardiology)
- Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. (Journal of the American Medical Association (JAMA))
- [Executive summary of the guidelines on the diagnosis and treatment of acute heart failure]. (Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology)
- Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. (Circulation)
- Guidelines for the diagnosis and treatment of chronic heart failure. (European Heart Journal)
- Impact of Obesity on Plasma Natriuretic Peptide Levels (Circulation)
- Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. (New England Journal of Medicine)
- Plasma brain natriuretic peptide concentration: impact of age and gender. (Journal of the American College of Cardiology)
- The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. (Journal of the American College of Cardiology)
- Plasma natriuretic peptide levels and the risk of cardiovascular events and death. (New England Journal of Medicine)
Their papers
- The war against heart failure: the Lancet lecture. (2015) — 736 citations
- Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. (2004) — 1,397 citations
- Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure (2019) — 994 citations
- Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. (2017) — 1,112 citations
- Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction (2016) — 624 citations
- Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis. (2016) — 1,332 citations
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. (2015) — 2,926 citations
- Genetic Risk, Coronary Heart Disease Events, and the Clinical Benefit of Statin Therapy (2015) — 642 citations
- Long-term use of ticagrelor in patients with prior myocardial infarction. (2015) — 1,709 citations
- Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. (2015) — 1,285 citations
- Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial. (2015) — 623 citations
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. (2014) — 4,384 citations
- Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. (2013) — 3,241 citations
- Edoxaban versus warfarin in patients with atrial fibrillation. (2013) — 4,723 citations
- Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure with Preserved Ejection Fraction: A Randomized Clinical Trial (2013) — 1,126 citations
- Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome (2012) — 906 citations
- Rivaroxaban in patients with a recent acute coronary syndrome. (2012) — 1,841 citations
- A tale of coronary artery disease and myocardial infarction. (2012) — 986 citations
- Vorapaxar in the secondary prevention of atherothrombotic events. (2012) — 900 citations
- Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. (2011) — 1,214 citations